Free Trial

Ocular Therapeutix (OCUL) SEC Filings & 10K Form

Ocular Therapeutix logo
$7.25 -0.13 (-1.76%)
Closing price 02/20/2025 04:00 PM Eastern
Extended Trading
$7.32 +0.07 (+0.97%)
As of 02/20/2025 07:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Ocular Therapeutix SEC Filings

DateFilerForm TypeView
02/14/2025
6:32 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
5:46 AM
Ocular Therapeutix (Subject)
Opaleye Management Inc. (Filed by)
Form SCHEDULE 13G/A
02/13/2025
7:36 PM
Notman Donald (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
7:37 PM
Ocular Therapeutix (Issuer)
Waheed Nadia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
7:38 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
7:35 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
6:16 PM
Notman Donald (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:24 PM
Notman Donald (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:24 PM
Notman Donald (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2024
6:52 AM
Heier Jeffrey S. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
6:49 AM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
6:51 AM
Kaiser Peter (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
6:47 AM
Dugel Pravin (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
5:42 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
5:19 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
5:23 PM
Kaiser Peter (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
4:44 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
4:10 PM
Heier Jeffrey S. (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
4:49 PM
Ocular Therapeutix (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
11/14/2024
8:37 AM
Avoro Capital Advisors LLC (Filed by)
Ocular Therapeutix (Subject)
Form SC 13G
11/14/2024
6:30 AM
Ocular Therapeutix (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/14/2024
6:10 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:15 AM
Ocular Therapeutix (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
3:49 PM
Ocular Therapeutix (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/22/2024
5:06 PM
BlackRock, Inc. (Filed by)
Ocular Therapeutix (Subject)
Form SC 13G/A
10/16/2024
3:25 PM
Ocular Therapeutix (Subject)
Strassburger Philip C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/09/2024
4:31 PM
Anderman Todd (Reporting)
Ocular Therapeutix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/09/2024
4:32 PM
Anderman Todd (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2024
3:20 PM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
4:17 PM
Heier Jeffrey S. (Reporting)
Ocular Therapeutix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2024
4:18 PM
Kaiser Peter (Reporting)
Ocular Therapeutix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2024
4:20 PM
Heier Jeffrey S. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:21 PM
Kaiser Peter (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
7:01 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
4:17 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
4:19 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
3:18 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2024
4:10 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2024
3:36 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2024
4:32 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
3:15 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
How You Could Invest in Elon’s ‘Final Move’ (Ad)

What if I told you Elon Musk's next big venture could leave Tesla and SpaceX in the dust? It may sound unbelievable - but it's true. Elon's new AI startup could redefine the industry and create 10 TIMES more American millionaires than Tesla ever did. This isn't just another AI story. It's what I'm calling Elon's "Final Move."

Click here to learn EXACTLY what to do >>>
08/07/2024
6:23 AM
Ocular Therapeutix (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
6:13 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
3:30 PM
Mattessich Antony C. (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/26/2024
6:30 PM
LINDSTROM RICHARD L MD (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
5:38 PM
Graves Adrienne L (Reporting)
Ocular Therapeutix (Issuer)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
5:39 PM
Ocular Therapeutix (Issuer)
Warden Charles M (Reporting)
Warden Charles M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
5:40 PM
Ocular Therapeutix (Issuer)
Williams Leslie J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
5:40 PM
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
5:40 PM
Ocular Therapeutix (Issuer)
RAINES MERILEE (Reporting)
RAINES MERILEE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
5:41 PM
Hong Seung Suh (Reporting)
Ocular Therapeutix (Issuer)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:19 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
3:22 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
3:53 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/12/2024
3:20 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2024
3:23 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2024
8:03 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
4:26 PM
Ocular Therapeutix (Issuer)
Waheed Nadia (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/04/2024
4:28 PM
Ocular Therapeutix (Issuer)
Waheed Nadia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
8:15 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2024
4:17 PM
Mattessich Antony C. (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/29/2024
3:33 PM
Mattessich Antony C. (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/23/2024
3:16 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/23/2024
3:18 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2024
3:20 PM
Ocular Therapeutix (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
3:22 PM
Ocular Therapeutix (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/29/2024
3:19 PM
Ocular Therapeutix (Filer)
Form ARS
03/29/2024
4:11 PM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
3:23 PM
Ocular Therapeutix (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2024
3:43 PM
Ocular Therapeutix (Issuer)
SUMMER ROAD LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
7:02 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/26/2024
7:04 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/26/2024
7:06 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
7:07 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
7:00 AM
Ocular Therapeutix (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/22/2024
6:34 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:OCUL) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners